How to buy Constellation Pharmaceuticals stock

Constellation Pharmaceuticals, Inc is a biotechnology business based in the US. Constellation Pharmaceuticals shares (CNST) are listed on the NASDAQ and all prices are listed in US Dollars. Constellation Pharmaceuticals employs 154 staff and has a market cap (total outstanding shares value) of USD$1.2 billion.

How to buy shares in Constellation Pharmaceuticals

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Constellation Pharmaceuticals. Find the stock by name or ticker symbol: CNST. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Constellation Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Constellation Pharmaceuticals, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Constellation Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Active investors

Webull

Our top pick for

Building a portfolio

Sofi Invest

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for active investors. We picked Webull for this category because its platform offers features that cater to advancing investors as well as beginners. The desktop app is outfitted with an extensive set of research tools, the mobile app gets high grades from users and traders can test strategies with a paper-trading feature.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.

What's in this guide?

1. CNST shares summary
2. Compare share dealing platforms
3. Is CNST stock a buy or sell?
4. Stock performance over time
5. Can I short CNST shares?
6. Constellation Pharmaceuticals's financials
7. How volatile are CNST shares?
8. Does Constellation Pharmaceuticals pay a dividend?
9. Other common questions

Constellation Pharmaceuticals share price

Use our graph to track the performance of CNST stocks over time.

Constellation Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-03-03.

52-week range	USD$17 - USD$50.9
50-day moving average	USD$33.19
200-day moving average	USD$26.3827
Wall St. target price	USD$47.75
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-3.125

Buy Constellation Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Webull		$0	Stocks, Options, ETFs	$0	0%	Get two free stock valued between $2.50 and $250 Open an account	Margin financing rates start at 3.99%. No monthly subscription fees for margin.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options, Mutual funds	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Constellation Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Constellation Pharmaceuticals, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Constellation Pharmaceuticals shares

There are currently 5.8 million Constellation Pharmaceuticals shares held short by investors – that's known as Constellation Pharmaceuticals's "short interest". This figure is 1.2% down from 5.9 million last month.

There are a few different ways that this level of interest in shorting Constellation Pharmaceuticals shares can be evaluated.

Constellation Pharmaceuticals's "short interest ratio" (SIR)

Constellation Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Constellation Pharmaceuticals shares currently shorted divided by the average quantity of Constellation Pharmaceuticals shares traded daily (recently around 464733.25301205). Constellation Pharmaceuticals's SIR currently stands at 12.45. In other words for every 100,000 Constellation Pharmaceuticals shares traded daily on the market, roughly 12450 shares are currently held short.

However Constellation Pharmaceuticals's short interest can also be evaluated against the total number of Constellation Pharmaceuticals shares, or, against the total number of tradable Constellation Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Constellation Pharmaceuticals's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Constellation Pharmaceuticals shares in existence, roughly 120 shares are currently held short) or 0.1769% of the tradable shares (for every 100,000 tradable Constellation Pharmaceuticals shares, roughly 177 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Constellation Pharmaceuticals.

Find out more about how you can short Constellation Pharmaceuticals stock.

Constellation Pharmaceuticals share price volatility

Over the last 12 months, Constellation Pharmaceuticals's shares have ranged in value from as little as $17 up to $50.9. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Constellation Pharmaceuticals's is 2.7672. This would suggest that Constellation Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Constellation Pharmaceuticals overview

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics to address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. Its lead product candidates include CPI-0610 that is in Phase II clinical trials for the treatment of patients with myelofibrosis in combination with ruxolitinib; and CPI-1205 that is in Phase Ib/II clinical trials for metastatic castration-resistant prostate cancer in combination with androgen receptor signaling inhibitors. The company is also developing CPI-0209 that is in Phase I dose escalation portion of a Phase I/II clinical trial to treat solid tumors. The company was formerly known as Epigenetix, Inc. and changed its name to Constellation Pharmaceuticals, Inc. in March 2008. Constellation Pharmaceuticals, Inc. was founded in 2008 and is based in Cambridge, Massachusetts.

Frequently asked questions

• What percentage of Constellation Pharmaceuticals is owned by insiders or institutions?

  Currently 0.754% of Constellation Pharmaceuticals shares are held by insiders and 104.217% by institutions.

• How many people work for Constellation Pharmaceuticals?

  Latest data suggests 154 work at Constellation Pharmaceuticals.

• When does the fiscal year end for Constellation Pharmaceuticals?

  Constellation Pharmaceuticals's fiscal year ends in December.

• Where is Constellation Pharmaceuticals based?

  Constellation Pharmaceuticals's address is: 215 First Street, Cambridge, MA, United States, 02142

• What is Constellation Pharmaceuticals's ISIN number?

  Constellation Pharmaceuticals's international securities identification number is: US2103731061

• What is Constellation Pharmaceuticals's CUSIP number?

  Constellation Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 210373106